Exogenous markers for the characterization of human diseases associated with oxidative stress

Biochimie

Volumn 95, Issue 3, 2013, Pages 578-584

  Vaya, Jacob ^a  

^a TEL HAI COLLEGE   (Israel)

Author keywords

Biomarker; Oxidative stress; Oxysterol; Parkinson's disease

Indexed keywords

2' DEOXYRIBOSE GUANOSINE; ARYLDIALKYLPHOSPHATASE 1; BIOLOGICAL MARKER; CHOLESTEROL; GLUTATHIONE; LINOLEIC ACID; LINOLEOYL TYROSINE 2' DEOXYGUANOSINE; LINOLEOYL TYROSINE 8 OXODEOXYGUANOSINE; NUCLEIC ACID; OXYSTEROL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; TYROSINE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; ATHEROSCLEROSIS; BLOOD ANALYSIS; COVALENT BOND; DIABETES MELLITUS; ENDOTHELIUM CELL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MACROPHAGE; MASS SPECTROMETRY; MICRODIALYSIS; NERVE CELL; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; SALIVA ANALYSIS; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; DISEASE; HUMANS; MICRODIALYSIS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 84874107705     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.03.005     Document Type: Article

References (20)

1. D. Trachootham, W. Lu, M.A. Ogasawara, R.D. Nilsa, and P. Huang Redox regulation of cell survival Antioxid. Redox Signal 10 2008 1343 1374
2. R.G. Allen, and M. Tresini Oxidative stress and gene regulation Free Radic. Biol. Med. 28 2000 463 499
3. L. Iuliano The oxidant stress hypothesis of atherogenesis Lipids 36 2001 S41 S44
4. J.M. Gutteridge Lipid peroxidation and antioxidants as biomarkers of tissue damage Clin. Chem. 41 1995 1819 1828
5. B.A. Janowski, M.J. Grogan, S.A. Jones, G.B. Wisely, S.A. Kliewer, E.J. Corey, and D.J. Mangelsdorf Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta Proc. Natl. Acad. Sci. U S A 96 1999 266 271
6. H.R. Griffiths, L. Moller, G. Bartosz, A. Bast, C. Bertoni-Freddari, A. Collins, M. Cooke, S. Coolen, G. Haenen, A.M. Hoberg, S. Loft, J. Lunec, R. Olinski, J. Parry, A. Pompella, H. Poulsen, H. Verhagen, and S.B. Astley Biomarkers Mol. Aspects Med. 23 2002 101 208
7. S. Ducheix, J.M. Lobaccaro, P.G. Martin, and H. Guillou Liver X receptor: an oxysterol sensor and a major player in the control of lipogenesis Chem. Phys. Lipids 164 2011 500 514
8. M.M. Tarpey, D.A. Wink, and M.B. Grisham Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 2004 R431 R444
9. B. Halliwell, and M. Whiteman Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br. J. Pharmacol. 142 2004 231 255
10. A. Azzi Oxidative stress: a dead end or a laboratory hypothesis? Biochem. Biophys. Res. Commun. 362 2007 230 232
11. A. Szuchman, M. Aviram, K. Soliman, S. Tamir, and J. Vaya Exogenous N-linoleoyl tyrosine marker as a tool for the characterization of cellular oxidative stress in macrophages Free Radic. Res. 40 2006 41 52
12. S. Khatib, R. Musa, and J. Vaya An exogenous marker: a novel approach for the characterization of oxidative stress Bioorg. Med. Chem. 15 2007 3661 3666
13. A. Szuchman, M. Aviram, S. Tamir, and J. Vaya Cholesterol, linoleic acid or/and tyrosine yield different spectra of products when oxidized alone or in a mixture: studies in various oxidative systems Free Radic. Res. 37 2003 1277 1288
14. J. Vaya, W. Song, S. Khatib, G. Geng, and H.M. Schipper Effects of heme oxygenase-1 expression on sterol homeostasis in rat astroglia Free Radic. Biol. Med. 42 2007 864 871
15. A. Szuchman, M. Aviram, R. Musa, S. Khatib, and J. Vaya Characterization of oxidative stress in blood from diabetic vs. hypercholesterolaemic patients, using a novel synthesized marker Biomarkers 13 2008 119 131
16. H. Tavori, M. Aviram, S. Khatib, R. Musa, S. Nitecki, A. Hoffman, and J. Vaya Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects Free Radic. Biol. Med. 46 2009 607 615
17. Y. Aluf, J. Vaya, S. Khatib, and J.P. Finberg Alterations in striatal oxidative stress level produced by pharmacological manipulation of dopamine as shown by a novel synthetic marker molecule Neuropharmacology 61 2011 87 94
18. Y. Aluf, J. Vaya, S. Khatib, Y. Loboda, S. Kizhner, and J.P. Finberg Specific oxidative stress profile associated with partial striatal dopaminergic depletion by 6-hydroxydopamine as assessed by a novel multifunctional marker molecule Free Radic. Res. 44 2010 635 644
19. U. Diczfalusy Analysis of cholesterol oxidation products in biological samples J. AOAC Int. 87 2004 467 473
20. H. Tavori, M. Aviram, S. Khatib, R. Musa, D. Mannheim, R. Karmeli, and J. Vaya Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion Free Radic. Biol. Med. 51 2011 234 242